Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a41fe616852000e31287401ad97272 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-141 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2330-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-31 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1135 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
filingDate |
2013-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_601a10abfa397933cf258e3426a00848 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fed09886141580d179576246370ea97a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2239e1409511932c37cb248e5eebe348 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ec95e452b09e7a8649187e04df74ec8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4a43e6ea814c8c7d0ff4abe4324a6fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0138dd67507ec9c00bdca5c7e796f80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_910841bf9be847488008889f7f1e043f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbf1cc6ed8273de0c97be9e511909494 |
publicationDate |
2014-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2014072357-A1 |
titleOfInvention |
Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated b-raf pathway |
abstract |
The invention relates to the therapeutic use of a combination in a disease and condition associated with melanoma or a disease or a condition associated with activated BRAF pathway. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109646680-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4035659-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11129830-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10350207-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11510919-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108135896-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10543232-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11040027-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11298376-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2720509-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022074152-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023079142-A2 |
priorityDate |
2012-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |